Equities Analysts Issue Forecasts for Henry Schein, Inc.’s FY2018 Earnings (HSIC)

Henry Schein, Inc. (NASDAQ:HSIC) – Equities researchers at Piper Jaffray Companies lowered their FY2018 EPS estimates for Henry Schein in a research note issued on Tuesday, November 6th. Piper Jaffray Companies analyst S. James now forecasts that the company will post earnings of $4.16 per share for the year, down from their prior estimate of $4.17. Piper Jaffray Companies also issued estimates for Henry Schein’s Q2 2019 earnings at $1.10 EPS.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, November 6th. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.02. Henry Schein had a return on equity of 20.40% and a net margin of 3.00%. The company had revenue of $3.28 billion for the quarter, compared to analyst estimates of $3.37 billion. During the same period in the prior year, the company posted $0.87 EPS. The company’s revenue was up 3.8% compared to the same quarter last year.

A number of other research firms also recently weighed in on HSIC. BidaskClub raised Henry Schein from a “hold” rating to a “buy” rating in a research note on Wednesday, August 22nd. Zacks Investment Research upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $86.00 price objective for the company in a research report on Wednesday, July 25th. Leerink Swann set a $100.00 target price on Henry Schein and gave the stock a “buy” rating in a report on Tuesday, August 7th. Barrington Research restated a “buy” rating and issued a $92.00 price objective on shares of Henry Schein in a report on Tuesday, August 7th. Finally, Craig Hallum raised their price objective on Henry Schein from $83.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday, August 7th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $84.41.

NASDAQ HSIC opened at $86.97 on Friday. The company has a market cap of $12.79 billion, a P/E ratio of 24.16, a price-to-earnings-growth ratio of 2.56 and a beta of 0.87. Henry Schein has a one year low of $62.56 and a one year high of $90.52. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.68 and a current ratio of 1.30.

Several hedge funds have recently added to or reduced their stakes in HSIC. NEXT Financial Group Inc purchased a new position in Henry Schein during the 3rd quarter worth approximately $103,000. McAdam LLC acquired a new stake in shares of Henry Schein during the 3rd quarter worth approximately $104,000. Squar Milner Financial Services LLC acquired a new stake in Henry Schein in the 2nd quarter valued at $120,000. Piedmont Investment Advisors LLC acquired a new stake in Henry Schein in the 2nd quarter valued at $130,000. Finally, Fuller & Thaler Asset Management Inc. grew its stake in Henry Schein by 57.1% in the 2nd quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock valued at $160,000 after acquiring an additional 800 shares during the period.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Story: Day Trading – Risk Worth the Reward?

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply